Serum lipid profiles among patients initiating ritonavir-boosted atazanavir versus efavirenz-based regimens (Q37266368)

19 August 2017

Serum lipid profiles among patients initiating ritonavir-boosted atazanavir versus efavirenz-based regimens (English)

1 reference

19 August 2017

1 reference

1 reference

1 reference

Stephen J Gange

8

0 references

Anuradha Ganesan

1

object named as

Anuradha Ganesan

1 reference

19 August 2017

Nancy F Crum-Cianflone

5

object named as

Nancy Crum-Cianflone

1 reference

19 August 2017

3

Elizabeth T Golub

1 reference

19 August 2017

Lorie Benning

2

1 reference

19 August 2017

Mark Riddle

4

1 reference

19 August 2017

Sybil Tasker

6

1 reference

19 August 2017

Lisa Jacobson

7

1 reference

19 August 2017

22 June 2009

1 reference

AIDS Research and Therapy

19 August 2017

1 reference

19 August 2017

6

1 reference

19 August 2017

13

1 reference

https://scigraph.springernature.com/pub.10.1186/1742-6405-6-13

19 August 2017

0 references

cites work

Predictive value of known and novel alleles of CYP2B6 for efavirenz plasma concentrations in HIV-infected individuals.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2712469

Associations among race/ethnicity, ApoC-III genotypes, and lipids in HIV-1-infected individuals on antiretroviral therapy

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2712469

Comparisons of causes of death and mortality rates among HIV-infected persons: analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2712469

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2712469

The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2712469

Do we still need a cohort study of women with HIV infection?

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2712469

Efficacy and safety of atazanavir, with or without ritonavir, as part of once-daily highly active antiretroviral therapy regimens in antiretroviral-naive patients

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2712469

Contribution of 20 single nucleotide polymorphisms of 13 genes to dyslipidemia associated with antiretroviral therapy.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2712469

The efavirenz-induced increase in HDL-cholesterol is influenced by the multidrug resistance gene 1 C3435T polymorphism.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2712469

Comparison of once-daily atazanavir with efavirenz, each in combination with fixed-dose zidovudine and lamivudine, as initial therapy for patients infected with HIV.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2712469

Lipid profiles in HIV-infected patients receiving combination antiretroviral therapy: are different antiretroviral drugs associated with different lipid profiles?

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2712469

Class of Antiretroviral Drugs and the Risk of Myocardial Infarction

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2712469

Genetic factors influencing atazanavir plasma concentrations and the risk of severe hyperbilirubinemia

3 December 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19545433

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The Women's Interagency HIV Study. WIHS Collaborative Study Group

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19545433

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1742-6405-6-13

1 reference

Dimensions Publication ID

19 August 2017

0 references

1 reference

19 August 2017

1 reference